Log In
BCIQ
Print this Print this
 

PTG-100

  Manage Alerts
Collapse Summary General Information
Company Protagonist Therapeutics Inc.
DescriptionIntegrin alpha(4)beta(7) peptide antagonist
Molecular Target Integrin alpha(4)beta(7)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat inflammatory bowel diseases (IBD); Treat moderate-to-severe ulcerative colitis (UC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today